Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Fluoroquinolone; topoisomerase IV, topoisomeras...
Src and Abl inhibitor.
Cysteine protease inhibitor.
Caffeic acid derivative.
Non-endogenous essential amino acid found in me...
Synthetic steroid; glucocorticoid agonist.
Azalide macrolide; protein translation inhibito...
p110δ PI3K inhibitor.
Piperazine; 5-HT1 agonist, 5-HT2/3 and α2-adre...
Peptide; NK2 antagonist.
LRRK2 inhibitor.
Glutathione-sulforaphane conjugate, antioxidant...
Benzazepine derivative; D1 partial agonist, pot...
β1/2-adrenergic antagonist.
Sesquiterpene lactone derived from Artemesia.
Toxin found in Aconitum; voltage-gated Na+ chan...
β-adrenergic antagonist, Kv1.4 and K2P2 K+ cha...
pan-PI3K inhibitor
Endogenous peptide hormone derived from POMC, i...
11β-HSD1 inhibitor.